{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T08:14:37Z","timestamp":1788250477585,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s11060-026-05710-4","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T18:06:44Z","timestamp":1784225204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Blood immune profiling predicts surgical anatomy and facial nerve outcome in Vestibular Schwannoma"],"prefix":"10.1007","volume":"179","author":[{"given":"Chen","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiangyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixu","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyou","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianping","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangqian","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengbo","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaohua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunke","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houshi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqing","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"issue":"2","key":"5710_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1177\/01945998211042006","volume":"167","author":"JP Marinelli","year":"2022","unstructured":"Marinelli JP, Beeler CJ, Carlson ML, Caye-Thomasen P, Spear SA, Erbele ID (2022) Global incidence of sporadic vestibular schwannoma: a systematic review. Otolaryngol. Head neck Surg 167(2):209\u2013214. https:\/\/doi.org\/10.1177\/01945998211042006","journal-title":"Otolaryngol.- -Head neck Surg"},{"issue":"7","key":"5710_CR2","doi-asserted-by":"publisher","first-page":"6522","DOI":"10.3390\/ijms24076522","volume":"24","author":"D Cazzador","year":"2023","unstructured":"Cazzador D, Astolfi L, Daloiso A, Tealdo G, Simoni E, Mazzoni A, Zanoletti E, Marioni G (2023) Tumor microenvironment in sporadic vestibular schwannoma: a systematic, narrative review. IJMS 24(7):6522. https:\/\/doi.org\/10.3390\/ijms24076522","journal-title":"IJMS"},{"issue":"14","key":"5710_CR3","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1056\/NEJMra2020394","volume":"384","author":"ML Carlson","year":"2021","unstructured":"Carlson ML, Link MJ (2021) Vestibular schwannomas. N Engl J Med 384(14):1335\u20131348. https:\/\/doi.org\/10.1056\/NEJMra2020394","journal-title":"N Engl J Med"},{"issue":"11","key":"5710_CR4","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1016\/j.mayocp.2020.03.033","volume":"95","author":"M Peris-Celda","year":"2020","unstructured":"Peris-Celda M, Graffeo CS, Perry A, Kleinstern G, Kerezoudis P, Driscoll CLW, Carlson ML, Link MJ (2020) Beyond the ABCs: hearing loss and quality of life in vestibular schwannoma. Mayo Clin Proc 95(11):2420\u20132428. https:\/\/doi.org\/10.1016\/j.mayocp.2020.03.033","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"5710_CR5","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1007\/s10143-020-01380-6","volume":"44","author":"G Grinblat","year":"2021","unstructured":"Grinblat G, Dandinarasaiah M, Braverman I, Taibah A, Lisma DG, Sanna M (2021) \u201cLarge and giant vestibular schwannomas: overall outcomes and the factors influencing facial nerve function\u201d. Neurosurg Rev 44(4):2119\u20132131. https:\/\/doi.org\/10.1007\/s10143-020-01380-6","journal-title":"Neurosurg Rev"},{"issue":"2","key":"5710_CR6","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1148\/radiol.2015151075","volume":"277","author":"Z Yin","year":"2015","unstructured":"Yin Z, Glaser KJ, Manduca A, Van Gompel JJ, Link MJ, Hughes JD, Romano A, Ehman RL, Huston J (2015) Slip interface imaging predicts tumor-brain adhesion in vestibular schwannomas. Radiology 277(2):507\u2013517. https:\/\/doi.org\/10.1148\/radiol.2015151075","journal-title":"Radiology"},{"key":"5710_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/B978-0-12-824534-7.00014-7","volume":"212","author":"CJ Hannan","year":"2025","unstructured":"Hannan CJ, Raghunathan A, Van Gompel JJ, Pathmanaban O (2025) Pathology and tumor microenvironment of vestibular schwannoma. Handb Clin Neurol 212:47\u201357. https:\/\/doi.org\/10.1016\/B978-0-12-824534-7.00014-7","journal-title":"Handb Clin Neurol"},{"key":"5710_CR8","doi-asserted-by":"publisher","unstructured":"Gregory GE, Haley MJ, Jones AP, Hannan CJ, Evans DG, King AT, Paszek P, Pathmanaban ON, Couper KN, Brough D (2024) Alternatively activated macrophages are associated with faster growth rate in vestibular schwannoma. Brain Commun 6(6):fcae400. https:\/\/doi.org\/10.1093\/braincomms\/fcae400","DOI":"10.1093\/braincomms\/fcae400"},{"issue":"1","key":"5710_CR9","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1038\/s41467-025-57586-z","volume":"16","author":"AP Jones","year":"2025","unstructured":"Jones AP, Haley MJ, Meadows MH, Gregory GE, Hannan CJ, Simmons AK, Bere LD, Lewis DG, Oliveira P, Smith MJ, King AT, Evans DGR, Paszek P, Brough D, Pathmanaban ON, Couper KN (2025) Spatial mapping of immune cell environments in NF2-related schwannomatosis vestibular schwannoma. Nat Commun 16(1):2944. https:\/\/doi.org\/10.1038\/s41467-025-57586-z","journal-title":"Nat Commun"},{"issue":"1","key":"5710_CR10","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s13046-022-02473-4","volume":"41","author":"M Amit","year":"2022","unstructured":"Amit M, Xie T, Gleber-Netto FO, Hunt PJ, Mehta GU, Bell D, Silverman DA, Yaman I, Ye Y, Burks JK, Fuller GN, Gidley PW, Nader M-E, Raza SM, DeMonte F (2022) Distinct immune signature predicts progression of vestibular schwannoma and unveils a possible viral etiology. J Exp Clin Cancer Res 41(1):292. https:\/\/doi.org\/10.1186\/s13046-022-02473-4","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"5710_CR11","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/s41467-023-42762-w","volume":"15","author":"TF Barrett","year":"2024","unstructured":"Barrett TF, Patel B, Khan SM, Mullins RDZ, Yim AKY, Pugazenthi S, Mahlokozera T, Zipfel GJ, Herzog JA, Chicoine MR, Wick CC, Durakovic N, Osbun JW, Shew M, Sweeney AD, Patel AJ, Buchman CA, Petti AA, Puram SV, Kim AH (2024) Single-cell multi-omic analysis of the vestibular schwannoma ecosystem uncovers a nerve injury-like state. Nat Commun 15(1):478. https:\/\/doi.org\/10.1038\/s41467-023-42762-w","journal-title":"Nat Commun"},{"issue":"3","key":"5710_CR12","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1227\/neu.0000000000002252","volume":"92","author":"CJ Hannan","year":"2023","unstructured":"Hannan CJ, Lewis D, O\u2019Leary C, Waqar M, Brough D, Couper KN, Dyer DP, Vail A, Heal C, Macarthur J, Cooper C, Hammerbeck-Ward C, Evans DG, Rutherford SA, Lloyd SK, Mackenzie Freeman SR, Coope DJ, King AT, Pathmanaban ON (2023) Increased circulating chemokines and macrophage recruitment in growing vestibular schwannomas. Neurosurgery 92(3):581\u2013589. https:\/\/doi.org\/10.1227\/neu.0000000000002252","journal-title":"Neurosurgery"},{"issue":"1","key":"5710_CR13","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1186\/s12885-023-11699-0","volume":"23","author":"S Tiainen","year":"2023","unstructured":"Tiainen S, Nurmela V, Selander T, Turunen P, Pasonen-Sepp\u00e4nen S, Kettunen T, Kuittinen O, Auvinen P, R\u00f6nk\u00e4 A (2023) A practical prognostic peripheral blood-based risk model for the evaluation of the likelihood of a response and survival of metastatic cancer patients treated with immune checkpoint inhibitors. BMC Cancer 23(1):1186. https:\/\/doi.org\/10.1186\/s12885-023-11699-0","journal-title":"BMC Cancer"},{"issue":"1","key":"5710_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00262-022-03221-5","volume":"72","author":"C Wei","year":"2023","unstructured":"Wei C, Wang M, Gao Q, Yuan S, Deng W, Bie L, Ma Y, Zhang C, Li S, Luo S, Li N (2023) Dynamic peripheral blood immune cell markers for predicting the response of patients with metastatic cancer to immune checkpoint inhibitors. ImmunotherapyCancer Immunol Immunother 72(1):23\u201337. https:\/\/doi.org\/10.1007\/s00262-022-03221-5","journal-title":"ImmunotherapyCancer Immunol Immunother"},{"key":"5710_CR15","doi-asserted-by":"publisher","first-page":"1206631","DOI":"10.3389\/fimmu.2023.1206631","volume":"14","author":"W Ma","year":"2023","unstructured":"Ma W, Wei S, Long S, Tian EC, McLaughlin B, Jaimes M, Montoya DJ, Viswanath VR, Chien J, Zhang Q, Van Dyke JE, Chen S, Li T (2023) Dynamic evaluation of blood immune cells predictive of response to immune checkpoint inhibitors in NSCLC by multicolor spectrum flow cytometry. Front. Immunol 14:1206631. https:\/\/doi.org\/10.3389\/fimmu.2023.1206631","journal-title":"Front. Immunol"},{"issue":"2","key":"5710_CR16","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1182\/bloodadvances.2021005198","volume":"6","author":"C Botta","year":"2022","unstructured":"Botta C, Maia C, Garces JJ, Termini R, Perez C, Manrique I, Burgos L, Zabaleta A, Alignani D, Sarvide S, Merino J, Puig N, Cedena M-T, Rossi M, Tassone P, Gentile M, Correale P, Borrello I, Terpos E, Jelinek T, Paiva A, Roccaro A, Goldschmidt H, Avet-Loiseau H, Rosinol L, Mateos M-V, Martinez-Lopez J, Lahuerta J-J, Blad\u00e9 J, San-Miguel JF, Paiva, B (2022) FlowCT for the analysis of large immunophenotypic data sets and biomarker discovery in cancer immunology. Blood Adv 6(2):690\u2013703. https:\/\/doi.org\/10.1182\/bloodadvances.2021005198","journal-title":"Blood Adv"},{"issue":"3","key":"5710_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11060-026-05451-4","volume":"176","author":"J Feghali","year":"2026","unstructured":"Feghali J, Reddy SC, Ahmed AK, Maroufi SF, Selim O, Canales M, Bhandarkar S, Kramer P, Creighton F, Lim M, Xu R, Caplan JM, Bettegowda C, Weingart J, Brem H, Tamargo RJ, Jackson CM (2026) Pre-operative blood-based inflammatory indices and long-term facial nerve outcomes following vestibular schwannoma resection. J Neurooncol 176(3):191. https:\/\/doi.org\/10.1007\/s11060-026-05451-4","journal-title":"J Neurooncol"},{"issue":"12","key":"5710_CR18","doi-asserted-by":"publisher","first-page":"6686","DOI":"10.1073\/pnas.1913940117","volume":"117","author":"BP Nicolet","year":"2020","unstructured":"Nicolet BP, Guislain A, van Alphen FPJ, Gomez-Eerland R, Schumacher TNM, van den Biggelaar M, Wolkers MC (2020) CD29 identifies IFN-\u03b3\u2013producing human CD8 + T cells with an increased cytotoxic potential. Proc Natl Acad Sci USA 117(12):6686\u20136696. https:\/\/doi.org\/10.1073\/pnas.1913940117","journal-title":"Proc Natl Acad Sci USA"},{"issue":"18","key":"5710_CR19","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.3390\/cancers14184429","volume":"14","author":"S Leisz","year":"2022","unstructured":"Leisz S, Klause CH, Vital Dos Santos T, Haenel P, Scheer M, Simmermacher S, Mawrin C, Strauss C, Scheller C, Rampp S (2022) Vestibular schwannoma volume and tumor growth correlates with macrophage marker expression. Cancers (Basel) 14(18):4429. https:\/\/doi.org\/10.3390\/cancers14184429","journal-title":"Cancers (Basel)"},{"issue":"1","key":"5710_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00401-025-02883-6","volume":"149","author":"F Zhao","year":"2025","unstructured":"Zhao F, Teng XF, Zhang J, Li S-W, Wang L-M, Zhao H-G, Zhang S, Zhao C, Li P, Zhao X-B, Song S-H, Liu P-N (2025) Multiplatform molecular analyses reveal two molecular subgroups of NF2-related schwannomatosis vestibular schwannomas with distinct tumour microenvironment and therapeutic vulnerabilities. Acta Neuropathol 149(1):47. https:\/\/doi.org\/10.1007\/s00401-025-02883-6","journal-title":"Acta Neuropathol"},{"key":"5710_CR21","doi-asserted-by":"publisher","unstructured":"Zhang L, Kuo HC, Duhon BH, Adunka OF, Dodson EE, Hardesty DA, Prevedello DM, Otero JJ, Ren Y (2024) Identifying tumor microenvironment biomarkers in adherent and cystic vestibular schwannomas. Otol Neurotol 45(2):e113\u2013e122. https:\/\/doi.org\/10.1097\/MAO.0000000000004073","DOI":"10.1097\/MAO.0000000000004073"},{"issue":"1","key":"5710_CR22","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41467-023-40408-5","volume":"15","author":"SJ Liu","year":"2024","unstructured":"Liu SJ, Casey-Clyde T, Cho NW, Swinderman J, Pekmezci M, Dougherty MC, Foster K, Chen WC, Villanueva-Meyer JE, Swaney DL, Vasudevan HN, Choudhury A, Pak J, Breshears JD, Lang UE, Eaton CD, Hiam-Galvez KJ, Stevenson E, Chen K-H, Lien BV, Wu D, Braunstein SE, Sneed PK, Magill ST, Lim D, McDermott MW, Berger MS, Perry A, Krogan NJ, Hansen MR, Spitzer MH, Gilbert L, Theodosopoulos PV, Raleigh DR (2024) Epigenetic reprogramming shapes the cellular landscape of schwannoma. Nat Commun 15(1):476. https:\/\/doi.org\/10.1038\/s41467-023-40408-5","journal-title":"Nat Commun"},{"issue":"1","key":"5710_CR23","doi-asserted-by":"publisher","first-page":"7280","DOI":"10.1038\/s41467-021-27574-0","volume":"12","author":"Y Maeda","year":"2021","unstructured":"Maeda Y, Wada H, Sugiyama D, Saito T, Irie T, Itahashi K, Minoura K, Suzuki S, Kojima T, Kakimi K, Nakajima J, Funakoshi T, Iida S, Oka M, Shimamura T, Doi T, Doki Y, Nakayama E, Ueda R, Nishikawa H (2021) Depletion of central memory CD8+ T cells might impede the antitumor therapeutic effect of Mogamulizumab. Nat Commun 12(1):7280. https:\/\/doi.org\/10.1038\/s41467-021-27574-0","journal-title":"Nat Commun"},{"key":"5710_CR24","doi-asserted-by":"publisher","first-page":"1082195","DOI":"10.3389\/fcell.2022.1082195","volume":"10","author":"MK Blake","year":"2023","unstructured":"Blake MK, O\u2019Connell P, Aldhamen YA (2023) Fundamentals to therapeutics: epigenetic modulation of CD8+ T cell exhaustion in the tumor microenvironment. Front Cell Dev Biol 10:1082195. https:\/\/doi.org\/10.3389\/fcell.2022.1082195","journal-title":"Front Cell Dev Biol"},{"key":"5710_CR25","doi-asserted-by":"publisher","unstructured":"Kim CG, Kim G, Kim KH, Park S, Shin S, Yeo D, Shim HS, Yoon HI, Park SY, Ha S-J, Kim HR (2021) Distinct exhaustion features of T lymphocytes shape the tumor-immune microenvironment with therapeutic implication in patients with non-small-cell lung cancer. J Immunother Cancer 9(12):e002780. https:\/\/doi.org\/10.1136\/jitc-2021-002780","DOI":"10.1136\/jitc-2021-002780"},{"key":"5710_CR26","doi-asserted-by":"publisher","unstructured":"Lan X, Zebley CC, Youngblood B (2023) Cellular and molecular waypoints along the path of T cell exhaustion. Sci Immunol 8(87):eadg3868. https:\/\/doi.org\/10.1126\/sciimmunol.adg3868","DOI":"10.1126\/sciimmunol.adg3868"},{"issue":"27","key":"5710_CR27","doi-asserted-by":"publisher","first-page":"16072","DOI":"10.1073\/pnas.1918937117","volume":"117","author":"JI Griffiths","year":"2020","unstructured":"Griffiths JI, Wallet P, Pflieger LT, Stenehjem D, Liu X, Cosgrove PA, Leggett NA, McQuerry JA, Shrestha G, Rossetti M, Sunga G, Moos PJ, Adler FR, Chang JT, Sharma S, Bild AH (2020) Circulating immune cell phenotype dynamics reflect the strength of tumor\u2013immune cell interactions in patients during immunotherapy. Proc Natl Acad Sci USA 117(27):16072\u201316082. https:\/\/doi.org\/10.1073\/pnas.1918937117","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"5710_CR28","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1038\/s41467-023-40850-5","volume":"14","author":"Z Xiao","year":"2023","unstructured":"Xiao Z, Todd L, Huang L, Noguera-Ortega E, Lu Z, Huang L, Kopp M, Li Y, Pattada N, Zhong W, Guo W, Scholler J, Liousia M, Assenmacher C-A, June CH, Albelda SM, Pur\u00e9 E (2023) Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors. Nat Commun 14(1):5110. https:\/\/doi.org\/10.1038\/s41467-023-40850-5","journal-title":"Nat Commun"},{"issue":"5","key":"5710_CR29","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.trecan.2023.01.007","volume":"9","author":"L Arpinati","year":"2023","unstructured":"Arpinati L, Scherz-Shouval R (2023) From gatekeepers to providers: regulation of immune functions by cancer-associated fibroblasts. Trends Cancer 9(5):421\u2013443. https:\/\/doi.org\/10.1016\/j.trecan.2023.01.007","journal-title":"Trends Cancer"},{"issue":"5","key":"5710_CR30","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1158\/0008-5472.CAN-22-1890","volume":"83","author":"T Akiyama","year":"2023","unstructured":"Akiyama T, Yasuda T, Uchihara T, Yasuda-Yoshihara N, Tan BJY, Yonemura A, Semba T, Yamasaki J, Komohara Y, Ohnishi K, Wei F, Fu L, Zhang J, Kitamura F, Yamashita K, Eto K, Iwagami S, Tsukamoto H, Umemoto T, Masuda M, Nagano O, Satou Y, Saya H, Tan P, Baba H, Ishimoto T (2023) Stromal reprogramming through dual PDGFR\u03b1\/\u03b2 blockade boosts the efficacy of anti\u2013PD-1 immunotherapy in fibrotic tumors. Cancer Res 83(5):753\u2013770. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-1890","journal-title":"Cancer Res"},{"issue":"8","key":"5710_CR31","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.3390\/cancers14081947","volume":"14","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Manouchehri Doulabi E, Herre M, Cedervall J, Qiao Q, Miao Z, Hamidi A, Hellman L, Kamali-Moghaddam M, Olsson A-K (2022) Platelet-derived PDGFB promotes recruitment of cancer-associated fibroblasts, deposition of extracellular matrix and Tgf\u03b2 signaling in the tumor microenvironment. Cancers (Basel) 14(8):1947. https:\/\/doi.org\/10.3390\/cancers14081947","journal-title":"Cancers (Basel)"},{"issue":"6","key":"5710_CR32","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1007\/s00262-020-02793-4","volume":"70","author":"C Zamora","year":"2021","unstructured":"Zamora C, Riudavets M, Anguera G, Alserawan L, Sullivan I, Barba A, Serra J, Ortiz MA, Gallardo P, Perea L, Gavira J, Barnadas A, Majem M, Vidal S (2021) Circulating leukocyte\u2013platelet complexes as a predictive biomarker for the development of immune-related adverse events in advanced non-small cell lung cancer patients receiving anti-PD-(L)1 blocking agents. ImmunotherapyCancer Immunol Immunother 70(6):1691\u20131704. https:\/\/doi.org\/10.1007\/s00262-020-02793-4","journal-title":"ImmunotherapyCancer Immunol Immunother"},{"issue":"4","key":"5710_CR33","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3390\/cells9040855","volume":"9","author":"D Stoiber","year":"2020","unstructured":"Stoiber D, Assinger A (2020) Platelet-leukocyte interplay in cancer development and progression. Cells 9(4):855. https:\/\/doi.org\/10.3390\/cells9040855","journal-title":"Cells"},{"issue":"1","key":"5710_CR34","doi-asserted-by":"publisher","first-page":"18166","DOI":"10.1038\/s41598-022-23190-0","volume":"12","author":"L Zhang","year":"2022","unstructured":"Zhang L, Chen X, Zu S, Lu Y (2022) Characteristics of circulating adaptive immune cells in patients with colorectal cancer. Sci Rep 12(1):18166. https:\/\/doi.org\/10.1038\/s41598-022-23190-0","journal-title":"Sci Rep"},{"issue":"3","key":"5710_CR35","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s43018-023-00521-2","volume":"4","author":"DE Speiser","year":"2023","unstructured":"Speiser DE, Chijioke O, Schaeuble K, M\u00fcnz C (2023) CD4+ T cells in cancer. Nat Cancer 4(3):317\u2013329. https:\/\/doi.org\/10.1038\/s43018-023-00521-2","journal-title":"Nat Cancer"},{"issue":"10","key":"5710_CR36","doi-asserted-by":"publisher","first-page":"8760","DOI":"10.3390\/ijms24108760","volume":"24","author":"JY Noh","year":"2023","unstructured":"Noh JY, Jung H (2023) Natural killer cells and immunotherapy. IJMS 24(10):8760. https:\/\/doi.org\/10.3390\/ijms24108760","journal-title":"IJMS"},{"issue":"18","key":"5710_CR37","doi-asserted-by":"publisher","first-page":"9973","DOI":"10.3390\/ijms22189973","volume":"22","author":"F Hassouneh","year":"2021","unstructured":"Hassouneh F, Goldeck D, Pera A, van Heemst D, Slagboom PE, Pawelec G, Solana R (2021) Functional changes of T-cell subsets with age and CMV infection. IJMS 22(18):9973. https:\/\/doi.org\/10.3390\/ijms22189973","journal-title":"IJMS"},{"key":"5710_CR38","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.coviro.2020.07.013","volume":"44","author":"EC Semmes","year":"2020","unstructured":"Semmes EC, Hurst JH, Walsh KM, Permar SR (2020) Cytomegalovirus as an immunomodulator across the lifespan. Curr Opin Virol 44:112\u2013120. https:\/\/doi.org\/10.1016\/j.coviro.2020.07.013","journal-title":"Curr Opin Virol"},{"issue":"5","key":"5710_CR39","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.ccell.2024.04.008","volume":"42","author":"D Dyikanov","year":"2024","unstructured":"Dyikanov D, Zaitsev A, Vasileva T, Wang I, Sokolov AA, Bolshakov ES, Frank A, Turova P, Golubeva O, Gantseva A, Kamysheva A, Shpudeiko P, Krauz I, Abdou M, Chasse M, Conroy T, Merriam NR, Alesse JE, English N, Shpak B, Shchetsova A, Tikhonov E, Filatov I, Radko A, Bolshakova A, Kachalova A, Lugovykh N, Bulahov A, Kilina A, Asanbekov S, Zheleznyak I, Skoptsov P, Alekseeva E, Johnson JM, Curry JM, Linnenbach AJ, South AP, Yang E, Morozov K, Terenteva A et al. (2024) Comprehensive peripheral blood immunoprofiling reveals five immunotypes with immunotherapy response characteristics in patients with cancer. Cancer Cell 42(5):759\u2013779.e12. https:\/\/doi.org\/10.1016\/j.ccell.2024.04.008","journal-title":"Cancer Cell"},{"issue":"1","key":"5710_CR40","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/WCO.0000000000001442","volume":"39","author":"S Vasilijic","year":"2025","unstructured":"Vasilijic S, Moore LS, Stankovic KM (2025) Multimodal biomarker landscape in vestibular schwannoma. Curr Opin Neurol 39(1):72\u201382. https:\/\/doi.org\/10.1097\/WCO.0000000000001442","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"5710_CR41","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/s41467-026-68865-8","volume":"17","author":"S Lu","year":"2026","unstructured":"Lu S, Yin Z, Wu L, Sun Y, Chen J, Wu LMN, Oblinger JL, Blake DC, Xiu B, Landegger LD, Seist R, Ho W, Jones AP, Muzikansky A, Stankovic KM, Plotkin SR, Chang L-S, Xu L (2026) NKG2D upregulation sensitizes tumors to combined anti-PD1 and anti-VEGF therapy and prevents hearing loss. Nat Commun 17(1):1148. https:\/\/doi.org\/10.1038\/s41467-026-68865-8","journal-title":"Nat Commun"},{"key":"5710_CR42","doi-asserted-by":"publisher","unstructured":"Wang JW, Wang HL, Liu Q, Hu K, Shao L, Wan J-H (2022) Multidimensional modulation of systemic immune by neurosurgical tumor resection in patients with brain tumors. Immun Inflam Disease 10(10):e703. https:\/\/doi.org\/10.1002\/iid3.703","DOI":"10.1002\/iid3.703"},{"key":"5710_CR43","doi-asserted-by":"publisher","first-page":"123991","DOI":"10.1016\/j.wneu.2025.123991","volume":"198","author":"F Yang","year":"2025","unstructured":"Yang F, Zhou Q, Bi Y, Kudulaiti N, Fang C, Shan Q, Liu Y, Wang Z, Tan N, Lou M (2025) Programmatic strategies in the retrosigmoid approach for koos grade IV vestibular schwannomas: exploring surgical anatomy, technical nuances, and case series. World Neurosurg 198:123991. https:\/\/doi.org\/10.1016\/j.wneu.2025.123991","journal-title":"World Neurosurg"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05710-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05710-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05710-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:27:06Z","timestamp":1788247626000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05710-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["5710"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05710-4","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"12 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in this study were in accordance with the 1964 Helsinki Declaration and its later amendments. The study protocol was approved by the Institutional Review Board of Shanghai General Hospital (No. 363 [2026]). Written informed consent was obtained from all individual participants included in the study.","order":1,"name":"Ethics","label":"Human ethics and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1"}}